
Aggrifib Injection
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Tirofiban (5mg)
Overview Aggrifib Injection
Cardiofibrin Injection is an anticoagulant preventing the development of dangerous blood clots. It aids in preventing myocardial infarction in patients experiencing acute chest pain from reduced cardiac blood flow. Administration of Cardiofibrin Injection requires physician oversight; dosage and treatment duration are determined individually. Concurrently prescribed medications should continue as directed, even after injection. Common adverse effects include headache, hematoma, nausea, bruising, post-surgical bleeding, and hematuria/melena. Report any petechiae or blood in emesis, urine, or feces immediately. Caution is advised in certain patients. Prior to use, disclose any bleeding disorders, hepatic or renal impairment, breastfeeding status, and all other medications to your physician.
Primary Ingredients of Aggrifib Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Aggrifib Injection
Avoiding a heart attack
Major Benefits of Aggrifib Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Aggrifib Injection:
- Headache
- Nausea
- Hematoma
- Ecchymosis (discoloration of the skin resulting from bleeding underneath)
- Postoperative bleeding
- Blood in stool
- Blood in urine
How to use Aggrifib Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Aggrifib Injection works:
Aggrifib Injection is an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous thrombus formation and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Aggrifib Injection with alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Aggrifib Injection during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Aggrifib Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Irrelevant, given Aggrifib Injection's restricted application to inpatients.
KidneyCAUTION
Patients with kidney impairment should use Aggrifib Injection judiciously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Aggrifib Injection requires careful administration in individuals with hepatic impairment. Dosage modification of Aggrifib Injection might be necessary. Physician consultation is advised. Aggrifib Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Aggrifib Injection :
Should you forget a scheduled Aggrifib Injection, seek medical advice.
Facts to Know About Aggrifib Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based compounds |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | GPIIb/IIIa receptor antagonists |
